Nabihah Tayob

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.4Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772

Top 27%

0.742DataRank

Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Papers

Driven by 39 papers — median percentile 0. Top paper: “A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer”.

A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer

Nature Communications(2021)10.1038/s41467-021-25904-w

N/A

1.9DataRank · unranked

69 citations

Alexandre André Balieiro Anastácio da Costa, D. Gulhan, Elizabeth K. Lee, Su-Chun Cheng, Andrea E. Wahner Hendrickson +14 more

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

Nature Communications(2021)10.1038/s41467-021-25769-z

N/A

1.8DataRank · unranked

48 citations

Jennifer L. Guerriero, Romualdo Barroso‐Sousa, Tianyu Li, Tess A. O’Meara, Anita Giobbie‐Hurder +24 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Annals of Oncology(2023)10.1016/j.annonc.2023.08.004

N/A

1.7DataRank · unranked

58 citations

Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3045

N/A

1.5DataRank · unranked

64 citations

Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann, Lewis C. Cantley +10 more

Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies

Clinical Gastroenterology and Hepatology(2020)10.1016/j.cgh.2020.07.065

N/A

1.4DataRank · unranked

35 citations

Douglas A. Corley, Israel C. Christie, Lucy Almers, Ahmed K. Rahal, Peter Richardson +5 more

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005119

N/A

1.2DataRank · unranked

39 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Gerburg M. Wulf, Edward T. Richardson +10 more

Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2305

N/A

0.918DataRank · unranked

28 citations

Tianyu Li, Albert Grinshpun, Tim H. H. Coorens, Douglas Russo, Leilani Anderson +16 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772

Top 27%

0.742DataRank

Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

TP53-associated early breast cancer: new observations from a large cohort

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae074

Top 32%

0.620DataRank

Top 32%19 citations

Michele Bottosso, Tianyu Li, Natália Polidorio, Brittany Bychkovsky, Benjamin Verret +13 more

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-23-1711

N/A

0.596DataRank · unranked

15 citations

Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi +36 more

Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3089

N/A

0.596DataRank · unranked

52 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study

npj Breast Cancer(2021)10.1038/s41523-021-00287-9

N/A

0.593DataRank · unranked

51 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Lorenzo Trippa, Ricardo Pastorello +11 more

Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2834

N/A

0.538DataRank · unranked

35 citations

Nabihah Tayob, Livius Penter, MacLean Sellars, Anna Tarren, Vipheaviny Chea +19 more

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010430

N/A

0.416DataRank · unranked

15 citations

Noah Graham, Lestat R. Ali, Christina I. Herold, Jennifer Desrosiers, Khanh Do +13 more

A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.100974

N/A

0.416DataRank · unranked

15 citations

Niya Xiong, Andrea P. Myers, Nabihah Tayob, Victoria Engvold, Madeline Polak +14 more

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆

ESMO Open(2024)10.1016/j.esmoop.2024.103973

N/A

0.385DataRank · unranked

12 citations

Danielle Brandes Zakon, Qingchun Jin, Ava Strahan, Melissa Grimm, Melissa E. Hughes +15 more

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

npj Breast Cancer(2024)10.1038/s41523-023-00605-3

N/A

0.360DataRank · unranked

10 citations

Jia‐Ren Lin, Ricardo Pastorello, Ziming Du, Yu-An Chen, Madeline G Townsend +17 more

NMR Spectroscopy-Based Metabolomics of Platelets to Analyze Brain Tumors

Reports — Medical Cases Images and Videos(2021)10.3390/reports4040032

N/A

0.330DataRank · unranked

8 citations

Alessandra Audia, Anirudh Mukhopadhyay, José S. Enriquez, Dontrey Bourgeois, Nabihah Tayob +9 more

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort

Journal of Hepatology(2025)10.1016/j.jhep.2025.09.023

N/A

0.312DataRank · unranked

7 citations

Camden Lopez, Michelle Luster, K. Rajender Reddy, Neehar D. Parikh, Amit G. Singal +9 more

Germline and Somatic Fumarate Hydratase Testing in Atypical Uterine Leiomyomata

Cancer Prevention Research(2024)10.1158/1940-6207.capr-23-0535

N/A

0.269DataRank · unranked

5 citations

Katelyn M. Breen, Diane R. Koeller, Alison Schwartz, Zelei Yang, Hyeji Jun +7 more

Personalized statistical learning algorithms to improve the early detection of cancer using longitudinal biomarkers

Cancer Biomarkers(2022)10.3233/cbm-210307

N/A

0.241DataRank · unranked

4 citations

Ziding Feng, Nabihah Tayob

Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy

ESMO Open(2025)10.1016/j.esmoop.2025.105568

N/A

0.104DataRank · unranked

1 citations

Qi Jin, Agepati S. Raghavendra, Danielle Brandes Zakon, Melissa Grimm, Melissa E. Hughes +16 more

AXALAP: Phase Ib study of axatilimab in combination with olaparib in BRCA1/2 and PALB2 -associated metastatic HER2-negative breast cancer (BC).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps1143

N/A

0DataRank · unranked

0 citations

Adela Rodríguez Hernandez, Siddhartha Yadav, Ryan Buehler, Grace Augdahl, Tasnim Rahman +9 more

GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis

Hepatology(2021)10.1002/hep.32185

N/A

0DataRank · unranked

170 citations

Nabihah Tayob, Anand S. Mehta, Jorge A. Marrero, Hashem El‐Serag, Qingchun Jin +4 more

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

Gastroenterology(2021)10.1053/j.gastro.2021.01.233

N/A

0DataRank · unranked

159 citations

Yujin Hoshida, David J. Pinato, Jorge A. Marrero, Jean‐Charles Nault, Valérie Paradis +10 more

The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States

Clinical Gastroenterology and Hepatology(2022)10.1016/j.cgh.2022.01.047

N/A

0DataRank · unranked

221 citations

Fasiha Kanwal, Abeer Alsarraj, Rubén Hernáez, Hashem B. El‐Serag, Nabihah Tayob

Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?

Journal of Hepatology(2022)10.1016/j.jhep.2022.08.036

N/A

0DataRank · unranked

153 citations

Nabihah Tayob, Amit G. Singal, Neehar D. Parikh

DETECT: Development of Technologies for Early HCC Detection

Gastroenterology(2022)10.1053/j.gastro.2022.03.024

N/A

0DataRank · unranked

7 citations

Nicole E. Rich, George Cholankeril, Peng Zhang, Weihua Zeng, Shuyun Rao +9 more

Immunoassay Detects Salivary Anti-SSA/Ro-52 Autoantibodies in Seronegative Patients with Primary Sjögren’s Syndrome

ImmunoHorizons(2023)10.4049/immunohorizons.2300043

N/A

0DataRank · unranked

10 citations

Nabihah Tayob, Samantha Chiang, Wei Bin Fang, Jin Kyun Park, Hyun Mi Kwon +6 more

Data from Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532290.v1

Top 100%

0DataRank

Top 100%0 citations

Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann, Lewis C. Cantley +10 more

Data from Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532290

Top 100%

0DataRank

Top 100%0 citations

Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann, Lewis C. Cantley +10 more

Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530060.v1

Top 100%

0DataRank

Top 100%0 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

Data from Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

(2023)10.1158/1078-0432.c.6532794

N/A

0DataRank · unranked

0 citations

D. Gulhan, Victor Y. Mao, Antuan V. Tran, Madeline Polak, Niya Xiong +14 more

Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530060

Top 100%

0DataRank

Top 100%0 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

896 Characterizing macrophage heterogeneity in HR+/HER2- metastatic breast cancer reveals novel mechanisms of resistance

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0896

N/A

0DataRank · unranked

0 citations

Kenichi Shimada, Madeline G Townsend, Tianyu Li, Nabihah Tayob, Molly DiLullo +9 more

982 Immune mediated mechanisms of PARPi resistance in BRCA1-associated triple negative breast cancer (TNBC)

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0982

N/A

0DataRank · unranked

0 citations

Anita K. Mehta, Madeline G Townsend, Madisson Oliwa, Kelly F Zheng, Patrice A. Lee +6 more

A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis

Gastroenterology(2024)10.1053/j.gastro.2024.09.008

N/A

0DataRank · unranked

73 citations

Neehar D. Parikh, Lewis R. Roberts, Myron E. Schwartz, Mindie H. Nguyen, Alex S. Befeler +8 more

HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States

Hepatology(2024)10.1097/hep.0000000000000953

N/A

0DataRank · unranked

35 citations

Qingchun Jin, Nabihah Tayob, Emad A. Salem, Michelle Luster, Abeer Alsarraj +6 more

A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer

Clinical Breast Cancer(2025)10.1016/j.clbc.2025.05.009

N/A

0DataRank · unranked

0 citations

Xiangying Chu, Tarah J. Ballinger, Nisha Unni, Sarah Sinclair, Robert Wesolowski +9 more

Nabihah Tayob

Indexed papers

Top data-sharing exemplar

Papers